Adaltis

Adaltis is an international diagnostic company headquartered in Rome, Italy, specializing in the development, manufacturing, and marketing of In-Vitro Diagnostic (IVD) systems and reagents. The company provides a comprehensive range of solutions for clinical laboratories, including automated analyzers for immunology and clinical chemistry, as well as molecular diagnostic tools. Their product portfolio features well-known platforms such as the Personal Lab and NexGen, which support a wide array of assays for infectious diseases, oncology, and endocrinology. Adaltis operates globally, serving hospitals and private laboratories through an extensive distribution network. The company is currently a part of the Cerba HealthCare group following its acquisition by Lifebrain.